A high-definition spatially resolved metabolomics method to illuminate the metabolic specificity and interconnection across mouse brain
The brain's functions are governed by molecular metabolic networks. However, due to the sophisticated spatial organization and diverse activities of the brain, characterizing both the minute and large-scale metabolic activity across the entire brain and its numerous micro-regions remains incredibly challenging. Here, we offer a high-definition spatially resolved metabolomics technique to better understand the metabolic specialization and interconnection throughout the mouse brain using improved ambient mass spectrometry imaging. This method allows for the simultaneous mapping of thousands of metabolites at a 30 µm spatial resolution across the mouse brain, ranging from structural lipids to functional neurotransmitters. This approach effectively reveals the distribution patterns of delicate microregions and their distinctive metabolic characteristics. Using an integrated database, we annotated 259 metabolites, demonstrating that the metabolome and metabolic pathways are unique to each brain microregion. The distribution of metabolites, closely linked to functionally connected brain regions and their interactions, offers profound insights into the complexity of chemical processes and their roles in brain function. An initial dataset for future metabolomics research might be obtained from the high-definition mouse brain's spatial metabolome atlas. A tiny desorption probe featuring an off-axis solvent capillary with an inner diameter of 20 µm has been developed for AFADESI-MSI. This innovative probe not only enhances the spatial resolution of MSI to a high definition level but also enables spatially resolved metabolomics analysis without compromising sensitivity. Consequently, it brings to light the metabolic specificity and interconnections within the mouse brain.
Authors
- Zeper Abliz (ORCID: https://orcid.org/0000-0003-1553-8367)
- Xinyi Jiang (ORCID: https://orcid.org/0000-0002-0234-9359)
- Jianpeng Huang (ORCID: https://orcid.org/0000-0001-7962-0058)
- Jiamin Gao (ORCID: https://orcid.org/0000-0001-6350-233X)
- Yanhe Zhou
- Guanlin Xiao (ORCID: https://orcid.org/0000-0002-5912-8434)
- Tong Li (ORCID: https://orcid.org/0000-0002-9987-8256)
- Jiuming He (ORCID: https://orcid.org/0000-0002-6545-472X)
- Meng Yu (ORCID: https://orcid.org/0000-0003-3699-6957)
- Xiangyi Wang
- Xiuli Gao
- Junwen Shi
Institutions
- Minzu University of China (CN)
- Guiyang Medical University (CN)
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- National Medical Products Administration (CN)
- State Ethnic Affairs Commission (CN)
- Guizhou Magic Pharmaceutical (China) (CN)
Publication Details
- Journal
- Chinese Chemical Letters
- Published
- 2025-03-29
- DOI
- https://doi.org/10.1016/j.cclet.2025.111153
- Primary Topic
- Metabolomics and Mass Spectrometry Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00